Recent Articles
-
Increase sales with social brand ambassadors
Emma Fitzpatrick MarketingAdvertising reminds consumers that your business is truly the best out there. You've got the lowest prices and the highest quality! Unsurprisingly though, shoppers are bound to be skeptical of your thoughts on your business. After all, you're a biased source.
-
Data doesn’t lie: Remote monitoring works
Karen R. Thomas Medical & Allied HealthcareThere has been a lot of positive press lately about remote patient monitoring, but many wonder what the news really means for patients. Yes, telehealth can improve efficiencies, reduce re-hospitalizations and save money for the healthcare system, but is it actually helping patients?
-
How indecision can cripple your business
Candice Gottlieb-Clark Business Management, Services & Risk ManagementGary and Jason (not their real names) have been business partners for more than a decade. But while their joint practice is blooming, their partnership is in trouble. Why? Decision-making, essential to the forward momentum of their business, has been stalled.
-
Why can’t academic conferences be fun?
Linchi Kwok Travel, Hospitality & Event ManagementLast week, I attended the 2015 Annual ICHRIE (International Council on Hotel, Restaurant and Institutional Education) Summer Conference in Orlando, Florida. Like many other academic conferences, it was an annual event where a group of hospitality professors and graduate students get together to showcase their research and network with one another.
-
The ever-expanding road ahead in wind energy applications
Don Rosato EngineeringWind energy provides significant growth opportunities for composite plastic materials. The global market for composite materials in wind turbine production is projected to reach $4.7 billion by the end of 2015. Carbon fiber and other advanced composites are expected to play an increasing role in wind blade production, owing to the expansion of offshore installations and the adoption of larger-scale turbines that call for stiffer and lighter materials.
-
An educator’s guide to dyslexia specialist training
Stephanie Cork and Laurie Wagner EducationThere has been a lot of buzz lately in the education world about dyslexia, which affects as many as 1 in 5 children. Dyslexia is a neurological condition that affects fluent reading, spelling and writing skills. Remediating dyslexia requires training beyond what most teacher preparation programs offer.
-
How to avoid the next Cecil the Lion scandal
John McAdams Recreation & LeisureThe unfortunate story of Walter Palmer and Cecil the Lion has been all over the news during the last couple of weeks. While the exact details of the hunt are still somewhat murky, it certainly appears that Palmer and his guides made several avoidable mistakes that could have prevented this fiasco from happening.
-
Healthcare industry to CMS: Finalize the meaningful use rule
Scott E. Rupp Healthcare AdministrationA group of 18 industry stakeholders are urging the Centers for Medicare and Medicaid Services (CMS) to finalize the rule that sets meaningful use requirements for 2015 through 2017. This follows actions taken in May when some of the nation's leading professional organization executives in healthcare submitted formal comments on the proposed changes to the EHR Incentive Program.
-
The movement From STEM to STEAM
Brian Stack EducationIn an elementary classroom in southern California, teacher and educational consultant Sarah Weaver was working recently with a group of students to use marshmallows and spaghetti to build the tallest, freestanding structure possible. In her blog, she writes about this activity as a great way to promote communication, teamwork and creativity, while allowing students to get to know each other and develop an understanding of appropriate group work behavior.
-
Amarin, free speech and off-label drug promotion
Jason Poquette PharmaceuticalShould representatives of FDA-approved drugs be able to talk to physicians or pharmacists about off-label (i.e. unapproved) uses for their drug? Lately the "legal" answer has seemed to be "absolutely not." But a recent ruling by a New York federal judge on the side of Amarin Pharmaceuticals, related to alleged off-label promotion of their drug Vascepa, reopens the debate.